跳至主要内容
临床试验/CTRI/2017/08/009246
CTRI/2017/08/009246已完成2 期

Clinical Evaluation of hydro-alcoholic extract of Evolvulus alsinoides Linn. on biochemical markers in the Management of Essential Hypertension

Jamia Hamdard0 个研究点目标入组 57 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
Jamia Hamdard
入组人数
57

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with essential hypertension (stage I hypertension based on JNC-7 classification) preferably patients with systolic 140 -155 and diastolic 90-95 mm Hg
  • Clinically stable patients
  • Patients of both genders
  • Patients not taking any anti-hypertensive drugs
  • Patients willing to sign the informed consent form and participate in the trial voluntarily

排除标准

  • Stage II essential hypertension
  • Secondary hypertension
  • Diabetes mellitus and thyroid dysfunctions
  • Patients with acute infectious disease/s
  • Patients with systemic disorders like chronic liver, kidney or heart disease etc
  • Pregnant and lactating mothers
  • Terminally ill patients with infectious diseases like AIDS and Tuberculosis etc
  • Patients who fail to give consent
  • Patients who fail to follow up

研究者

发起方
Jamia Hamdard

相似试验

Effect of Unani medicine for essential hypertensio | 临床试验